Genpact (NYSE:G) is set to release its earnings data after the market closes on Monday, February 12th. Analysts expect Genpact to post earnings of $0.42 per share for the quarter.

Shares of Genpact (G) opened at $31.95 on Friday. Genpact has a 12 month low of $23.34 and a 12 month high of $34.79. The company has a market cap of $6,170.00, a P/E ratio of 23.15, a PEG ratio of 2.00 and a beta of 0.57. The company has a quick ratio of 1.65, a current ratio of 1.65 and a debt-to-equity ratio of 0.77.

A number of brokerages have recently commented on G. Cantor Fitzgerald reiterated a “buy” rating and issued a $36.00 price target on shares of Genpact in a research note on Wednesday, November 8th. Robert W. Baird reiterated a “buy” rating and issued a $38.00 price target on shares of Genpact in a research note on Friday, November 10th. Finally, Zacks Investment Research upgraded shares of Genpact from a “sell” rating to a “hold” rating and set a $35.00 price target for the company in a research note on Friday, November 10th. Three research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. Genpact presently has a consensus rating of “Buy” and an average price target of $33.38.

In related news, insider Private Ltd Gic sold 1,499,806 shares of the business’s stock in a transaction that occurred on Monday, November 20th. The shares were sold at an average price of $30.26, for a total transaction of $45,384,129.56. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Piyush Mehta sold 12,500 shares of the company’s stock in a transaction that occurred on Monday, November 27th. The stock was sold at an average price of $32.00, for a total transaction of $400,000.00. Following the completion of the transaction, the senior vice president now owns 77,944 shares of the company’s stock, valued at $2,494,208. The disclosure for this sale can be found here. Insiders have sold 1,660,470 shares of company stock valued at $50,598,982 over the last 90 days. 1.41% of the stock is currently owned by company insiders.

A hedge fund recently raised its stake in Genpact stock. The Manufacturers Life Insurance Company grew its position in Genpact Limited (NYSE:G) by 7.5% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 6,508 shares of the business services provider’s stock after purchasing an additional 455 shares during the quarter. The Manufacturers Life Insurance Company ‘s holdings in Genpact were worth $181,000 as of its most recent filing with the Securities and Exchange Commission (SEC). Hedge funds and other institutional investors own 91.99% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This piece of content was posted by Daily Political and is owned by of Daily Political. If you are reading this piece of content on another website, it was illegally stolen and republished in violation of United States and international trademark and copyright laws. The legal version of this piece of content can be accessed at https://www.dailypolitical.com/2018/02/09/genpact-g-to-release-earnings-on-monday.html.

About Genpact

Genpact Limited is engaged in providing digitally powered business process management and services. The Company is also engaged in designing, transforming and running a combination of processes, as well as providing solutions that combine elements of its service offerings. The Company’s segments include Business process outsourcing and Information technology services.

Earnings History for Genpact (NYSE:G)

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.